GALDERMA GROUP AG (GALDY) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $38.14 (+2.78%), Market cap $47.61B, P/E ratio 78.06, 52-week low–high $25.02 ~ $43.92.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Financial statements, price targets, institutional (13F) holdings and related news for GALDERMA GROUP AG are updated in real time on BlackAll Trade.
GALDERMA GROUP AG trades at $38.14 (+2.78%). Real-time quotes and charts are available on BlackAll Trade.
GALDERMA GROUP AG has a market cap of about $47.61B. Its P/E ratio is 78.06.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermat